News
FLHLF
0.037
NaN%
--
Weekly Report: what happened at FLHLF last week (0415-0419)?
Weekly Report · 4d ago
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Benzinga's psychedelic headlines roundup includes a look at the first two weeks of April 2024. Psilocybin could alter mechanisms associated with major depression and neurodegenerative diseases. Ancient Romans used to trip on hallucinogenic plants, archeologists say. Psycon's 2024 edition will take place in Colorado in May.
Benzinga · 04/17 13:13
Weekly Report: what happened at FLHLF last week (0408-0412)?
Weekly Report · 04/15 10:49
Weekly Report: what happened at FLHLF last week (0401-0405)?
Weekly Report · 04/08 10:54
Filament Health reports FY results
Filament Health Corp. Reports FY results. Cash used in operating activities of C$4.2M during the twelve months ended December 31, 2023. Cash and cash equivalents of C $1.8M as of March 31, 2024. The company's stock is traded on the OTCQB under the symbol FLHLF.
Seeking Alpha · 04/03 14:03
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Reuters · 04/03 01:58
Weekly Report: what happened at FLHLF last week (0325-0329)?
Weekly Report · 04/01 10:52
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Benzinga's psychedelic headlines roundup includes news from the last two weeks of March 2024. Psychedelic therapy as a form of life and the role of psychedelics in the management of chronic pain are among the topics. A new study shows psilocybin is a prodrug of psilocin. Frank Herbert’s magic mushrooms are available in Canada.
Benzinga · 03/30 12:57
Weekly Report: what happened at FLHLF last week (0318-0322)?
Weekly Report · 03/25 10:54
Weekly Report: what happened at FLHLF last week (0311-0315)?
Weekly Report · 03/18 10:53
Weekly Report: what happened at FLHLF last week (0304-0308)?
Weekly Report · 03/11 10:50
Weekly Report: what happened at FLHLF last week (0226-0301)?
Weekly Report · 03/04 10:53
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Benzinga's psychedelic headlines roundup includes a look at the last two weeks of February 2024. Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of the drug. A new survey is launched to understand the psychedelic therapy underground practices and how they differ from clinical trials.
Benzinga · 03/02 00:27
Weekly Report: what happened at FLHLF last week (0219-0223)?
Weekly Report · 02/26 11:03
Weekly Report: what happened at FLHLF last week (0212-0216)?
Weekly Report · 02/19 11:05
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Benzinga's psychedelics headlines roundup includes a look at the last few days of January and the first two weeks of February 2024. A review of Indigenous psilocybin mushroom practices: An annotated bibliography. Psychedelics center developed a new rating scale for the effects of MDMA, ketamine and other drugs.
Benzinga · 02/15 15:55
Weekly Report: what happened at FLHLF last week (0205-0209)?
Weekly Report · 02/12 10:56
Weekly Report: what happened at FLHLF last week (0129-0202)?
Weekly Report · 02/05 11:03
'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges
Magdalena Biosciences is a company that aims to develop medicines derived from plants for mental health conditions. The company is using a plant extract found in a botanical drug candidate for a potential treatment of ADHD, depression and anxiety. Magdalena's goal is to harness the power of ethnobotany to identify and evaluate traditional medicines.
Benzinga · 01/30 18:52
Weekly Report: what happened at FLHLF last week (0122-0126)?
Weekly Report · 01/29 10:54
More
Webull provides a variety of real-time FLHLF stock news. You can receive the latest news about Filament Health through multiple platforms. This information may help you make smarter investment decisions.
About FLHLF
Filament Health Corp. is a Canada-based natural psychedelic drug discovery and development company. The Company is engaged in natural extraction technologies utilizing patented and patent-pending processes to manufacture pharmaceutical grade psychoactive products. The Company operates through its Health Canada Dealer's license at its good manufacturing practice (GMP) drug discovery and manufacturing facility. The Company's wholly owned subsidiary includes Psilo Scientific Ltd. (Psilo). Psilo is a drug discovery and extraction technologies company.